Brian A. Leuthner
2021 - OncoSec Medical
In 2021, Brian A. Leuthner earned a total compensation of $1.7M as Former Interim Chief Executive Officer, Former Chief Operating Officer at OncoSec Medical.
Compensation breakdown
| Option Awards | $856,477 |
|---|---|
| Salary | $167,058 |
| Stock Awards | $606,720 |
| Other | $54,446 |
| Total | $1,684,701 |
Leuthner received $856.5K in option awards, accounting for 51% of the total pay in 2021.
Leuthner also received $167.1K in salary, $606.7K in stock awards and $54.4K in other compensation.
Rankings
In 2021, Brian A. Leuthner's compensation ranked 6,749th out of 12,406 executives tracked by ExecPay. In other words, Leuthner earned more than 45.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,749 out of 12,406 | 46th |
Division Manufacturing | 2,927 out of 5,492 | 47th |
Major group Chemicals And Allied Products | 1,292 out of 2,368 | 45th |
Industry group Drugs | 1,151 out of 2,089 | 45th |
Industry Pharmaceutical Preparations | 839 out of 1,536 | 45th |
Source: SEC filing on May 31, 2022.
Leuthner's colleagues
We found two more compensation records of executives who worked with Brian A. Leuthner at OncoSec Medical in 2021.